Vishal Marria, founder and chief executive of the London-based artificial intelligence start-up Quantexa, has stated that the company is prepared for an initial public offering (IPO) but faces no immediate pressure to go public. Marria described running Quantexa, valued at $2.6 billion, "as if it was already a public business," with established committees and processes typical of a publicly listed company. However, he emphasized that the priority remains on building a strong foundational business, and the decision to list will be made when the time is right.

Quantexa, founded in 2016, initially focused on unifying disparate data to combat fraud within financial services but has since broadened its scope. Its customer base includes firms such as Vodafone, Accenture, HSBC, NatWest, and various government agencies. Recently, the company secured a three-year contract worth £1.9 million with the Insolvency Service, marking its second public sector contract win of the year. The platform is intended to assist investigators in tackling issues such as money laundering in high-street businesses, Covid loan abuse, and “phoenixing,” where companies are abandoned to evade debts before reestablishing as new entities.

Earlier this year, Quantexa was awarded a £175 million, decade-long contract with Her Majesty’s Revenue and Customs (HMRC) aimed at addressing tax fraud and enhancing customer services. The company is also actively pursuing additional public sector opportunities.

A distinctive feature of Quantexa’s technology is that its platform operates within a customer’s own software environment, which Marria highlighted as crucial for maintaining control over sensitive data and artificial intelligence systems. He underscored the importance of technological sovereignty, saying organizations must have authority over data inputs, models, outputs, and feedback loops to ensure solutions are explainable, transparent, scalable, and manageable during times of distress.

Quantexa was part of a consortium that lost to Palantir in the tender for the NHS’s federated data platform project. Palantir’s ongoing involvement in this NHS programme has drawn public scrutiny, prompting government consideration of a contract break clause as part of broader efforts to promote British firms in public procurement. Marria expressed that government procurement should prioritize technology quality regardless of origin and indicated Quantexa’s intention to re-enter bidding if the contract is reopened.